BEGIN:VCALENDAR
VERSION:2.0
CALSCALE:GREGORIAN
PRODID:iCalendar-Ruby
BEGIN:VEVENT
CATEGORIES:Lectures & Presentations
DESCRIPTION:Chemistry Colloquium: Dr. Milind Deshpande\, Jan. 31\n\nDr. Mil
ind Deshpande will be the guest speaker for the Chemistry & Biochemistry Co
lloquium: New Treatment Modalities for Small Molecule Therapeutics and Busi
ness of Entrepreneurship: Incubation of Ideas and Company Creation. Dr. Des
hpande is a Venture Partner at RA Capital\, and President & CEO of Nayan Th
erapeutics\, a RA Capital portfolio company. Dr. Deshpande has more than 25
years of leadership and operational experience through all stages of drug
discovery and development. He is the co-founder and Chairman of the Board o
f Directors of Spero Therapeutics\, and past President\, CEO and member of
the Board of Directors of Achillion Pharmaceuticals. Prior to joining Achil
lion\, Dr. Deshpande was Group Leader at Bristol-Myers Squibb for all early
-stage discovery programs in infectious diseases and neuroscience. He is th
e co-inventor of first-in-class HCV NS5A inhibitors\, which led to the appr
oval of Daklinza™\, the first marketed drug in its class. He received his d
octorate in Organic Chemistry from Ohio University\, and was a Fellow and I
nstructor in Department of Medicine\, Boston University School of Medicine
DTEND:20240131T220500Z
DTSTAMP:20241122T190800Z
DTSTART:20240131T211000Z
GEO:39.322732;-82.10287
LOCATION:Walter Hall\, 145
SEQUENCE:0
SUMMARY:Chemistry Colloquium: Dr. Milind Deshpande\, Jan. 31
UID:tag:localist.com\,2008:EventInstance_45145036304408
URL:https://calendar.ohio.edu/event/chemistry_colloquium_dr_milind_deshpand
e
END:VEVENT
END:VCALENDAR